Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.
byBenzinga Newsdesk
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Volatility In Markets Decreases Ahead Of Apple, Amazon Earnings

By Lisa Levin
October 27, 2:18 AM
U.S. stocks closed mostly lower on Wednesday, with the S&P 500 ending a three-session winning streak. US new home sales fell to a 603,000 annual rate in September compared to a revised 677,000 a month ago, while trade gap on goods increased to a three-month high of $92.2 billion in September from a $87.3 billion deficit in the previous month.

AAPL

Read More

Investor Sentiment Drops Ahead Of US Jobs Report

By Lisa Levin
December 2, 4:02 AM
The CNN Money Fear and Greed index showed slight easing in overall market sentiment on Thursday after the Dow Jones relinquished some of the sharp gains recorded on Wednesday. The Dow gained more than 700 points on Wednesday after Federal Reserve Chair Jerome Powell suggested the central bank could begin easing back on its interest rate hikes starting as early as next month.

CBRL